OPTIPICK: Streamlining Participant Selection for Vital Clinical Trials

This study examines how artificial intelligence (AI) is changing the way that clinical trial participants are chosen, which is one way that AI is having a significant impact on healthcare. Clinical trials are essential to the advancement of medical technology because they thoroughly evaluate new medications and equipment. Through the use of advanced deep learning neural network models, an AI agent quickly examines people's health information and interactions to speed participant selection. Advanced algorithms detect qualified applicants in a timely manner and give accurate feedback regarding their trial eligibility. Adults between the ages of 20 and 60 can access it, guaranteeing demographic stability. Pharmaceutical businesses gain from accelerated participant identification, whereas individuals receive frequent updates on the status of their trials. Techniques for identity verification uphold the integrity of selection. Overall, the efficiency, accuracy, and transparency of trial recruitment are improved by this AI-driven methods, improving patient outcomes and medical research. As unique algorithms are integrated with machine learning and deep learning models, response times and prediction accuracy are improved over traditional methods.